Can You Halt the Progression of Heart Disease? Plaque build- up in our arteries usually happens over many years. Often, we don’t even know the damage is taking place. But boy oh boy, the end result - a heart attack - comes fast and furious. Learn how to halt arterial damage. So effective is the Pritikin lifestyle in reversing risk factors for heart disease that Medicare now reimburses for Pritikin’s diet- and- exercise programs for qualifying individuals with a history of cardiovascular events. Can I reverse the progression of coronary heart disease? Yes. To understand how, here’s a little background on how heart disease happens. Most heart disease results from atherosclerosis, which is cholesterol build- up, or plaque, in the artery’s inner walls. Plaque can burst or rupture, which triggers blood clots that may block blood flowing to the heart. The result is a heart attack. That’s the bad news. The good news is that with healthy lifestyle changes and, if needed, medications, many people are able to stabilize atherosclerosis, making plaque less likely to rupture. How did I get plaque in the first place? Plaque is caused by the piling up of LDL “bad” cholesterol and other apo. B- containing lipoproteins in the artery walls, resulting in inflammation. Collectively, these many damaging forms of cholesterol are known as non- HDL cholesterol. But keep in mind that cholesterol is not the only contributor to plaque build- up. Don't give in, don't give up! Regain control over your cardiovascular system. Reduce and/or regress atherosclerotic plaque deposits naturally. Penis Extion Erectile Dysfunction Drugs And High Blood Pressure=s31345 Penis Extion Male Enhancment Pills=s33483 Penis Extion Can Kegel Exercises Cure Erectile. Garlic REALLY is good for you: Extract 'reverses build-up of deadly plaque that clogs arteries and triggers heart attacks' Aged garlic extract reduces plaque buildup. In case your goal is to maintain a healthy heart, there is a variety of foods that can help you get rid of plaque in arteries, reduce inflammation and lower the blood. Can I reverse the progression of coronary heart disease? To understand how, here’s a little background on how heart disease happens. Most heart disease results. Intracranial artery stenosis Overview. Intracranial stenosis is a narrowing of an artery inside the brain. A buildup of plaque (atherosclerosis) inside the artery.
Other plaque producers include type 2 diabetes and high blood pressure, as well as precursors of these conditions, such as pre- diabetes (a fasting blood glucose of 1. L) and pre- hypertension, which is a resting blood pressure between 1. The more of these risk factors you have, the more plaque you likely have, and the more inflamed – and damaged – the inner walls of your arteries become. High levels of artery- damaging lipoproteins like LDL are the result of several factors. Some, such as genetics, age, and gender, are beyond our control. Others we can control. Three key dietary factors that clog arteries are: Saturated fats (such as butter, palm oil, coconut oil, meat fats, and milk fats like full- fat milk and cheese)Trans fats (found in margarines, vegetable shortenings, and partially hydrogenated oils)Dietary cholesterol (found ONLY in animal products, not plants)Losing excess weight. Another priority for improving heart health is losing excess body weight. That’s because being overweight or obese can adversely impact our cholesterol levels independent of the amount and type of dietary fat we’re eating. But certainly, all types of dietary fat can promote weight gain because all types of dietary fat, from vegetable oils to butter, are very calorie dense. Refined carbs, high- calorie drinks. Refined carbohydrates and especially sugar- rich beverages can also promote weight gain, and, in doing so, elevate apo. B- containing atherogenic lipoprotein levels. Fructose. What’s more, refined carbohydrates, particularly those containing fructose, and excess alcohol intake can lead to elevated levels of triglycerides, which increase heart attack risk. Tobacco smoke. Tobacco smoke can also damage arteries, making it easier for more blood cholesterol to end up in artery walls. How does plaque rupture lead to a heart attack? In most cases, plaque ruptures in much the same way a boil ruptures. The rupture then triggers a blood clot that chokes off blood flow to the heart. Without oxygen, heart muscle dies. Plaque that has burst or ruptured has been called the single most common lethal event of the industrial world. How long does it take to lower my risk of a heart attack? The really good news is that in just three to four weeks, the chances of suffering a heart attack can go way down. Very quickly, plaque can become far less vulnerable to rupture. By stabilizing plaque, most people can significantly lower their risk of a heart attack. How can I stabilize plaque and lower heart attack risk? Lifestyle changes can yield dramatic benefits. In more than 1. 00 studies published over the last 3. Pritikin Program has been found to lower virtually all modifiable risk factors for a heart attack, including LDL cholesterol, total cholesterol, triglyceride fats, and inflammatory markers like C- reactive protein, as well as high blood pressure, type 2 diabetes, and excess weight. Daily exercise and a diet that focuses on fiber- rich, unrefined carbohydrates like fruits, vegetables, beans, and whole grains are the hallmarks of the Pritikin Program. The program also substantially cuts down on heart- damaging saturated fats, trans fats, and dietary cholesterol. Heart disease is virtually absent in cultures that eat fiber- rich, plant- based diets like the Pritikin Program, such as the Tarahumara Indians of northern Mexico, the Papua Highlanders of New Guinea, and the people of rural China. Colin Campbell of Cornell University in his book The China Study, which details his research in the 1. China, hundreds of thousands of rural Chinese go for years without a single documented heart attack. Can the Pritikin Program help me avoid heart surgery? The Pritikin Program has been found to eliminate the need for coronary bypass surgery, as well as relieve angina (chest) pain. A five- year follow- up of 6. Pritikin Longevity Center instead of undergoing bypass surgery (which had been recommended by their heart surgeons) found that 8. Of those taking drugs for angina pain, 6. Center drug- free. The Pritikin Program has also been found to dramatically lower cholesterol levels. Among more than 4,5. Pritikin Longevity Center, documented in the Archives of Internal Medicine, LDL cholesterol fell on average 2. Several scientists, including Caldwell B. Esselstyn at the Cleveland Clinic Foundation, have found that plaques are stabilized, and actually shrink, when heart patients adopt lifestyle changes similar to the Pritikin Program. Summarized Dr. Esselstyn in Preventive Cardiology : “Compelling data from nutritional studies, population surveys, and interventional studies support the effectiveness of a plant- based diet and aggressive lipid . In essence, this is an offensive strategy.”A diet based on fiber- rich, whole foods, like the Pritikin Eating Plan, “can achieve total disease arrest and selective regression even in advanced cases,” concluded Dr. Esselstyn. Bottom Line: The Pritikin Program can reverse the progression of coronary heart disease, which can dramatically reduce heart attack risk. More Heart Health Articles. Angina Pectoris: Practice Essentials, Background, Pathophysiology. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Intramyocardial, autologous CD3. Prognosis of patients undergoing cardiac surgery and treated with intra- aortic balloon pump counterpulsation prior to surgery: a long- term follow- up study. Interact Cardiovasc Thorac Surg. Campbell AR, Satran D, Zenovich AG, et al. Enhanced external counterpulsation improves systolic blood pressure in patients with refractory angina. Oesterle SN, Sanborn TA, Ali N, et al. Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels. Crea F, Pupita G, Galassi AR, et al. Role of adenosine in pathogenesis of anginal pain. Kugiyama K, Yasue H, Okumura K, et al. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Rosano GM, Collins P, Kaski JC, et al. Syndrome X in women is associated with oestrogen deficiency. Kaski JC, Elliott PM, Salomone O, et al. Concentration of circulating plasma endothelin in patients with angina and normal coronary angiograms. Lanza GA, Giordano A, Pristipino C, et al. Abnormal cardiac adrenergic nerve function in patients with syndrome X detected by . Deedwania PC, Carbajal EV. Silent ischemia during daily life is an independent predictor of mortality in stable angina. Kuo L, Davis MJ, Chilian WM. Longitudinal gradients for endothelium- dependent and - independent vascular responses in the coronary microcirculation. Lloyd- Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics- -2. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Hemingway H, Langenberg C, Damant J, Frost C, Pyorala K, Barrett- Connor E. Prevalence of angina in women versus men: a systematic review and meta- analysis of international variations across 3. Tanindi A, Erkan AF, Ekici B. Epicardial adipose tissue thickness can be used to predict major adverse cardiac events. Li Z, Liu X, Wang J, et al. Analysis of urinary metabolomic profiling for unstable angina pectoris disease based on nuclear magnetic resonance spectroscopy. Gurses KM, Kocyigit D, Yalcin MU, et al. Enhanced platelet toll- like receptor 2 and 4 expression in acute coronary syndrome and stable angina pectoris. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. O'Keefe JH Jr, Barnhart CS, Bateman TM. Comparison of stress echocardiography and stress myocardial perfusion scintigraphy for diagnosing coronary artery disease and assessing its severity. ACCF/AHA 2. 00. 7 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2. Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the So.. Natural history of angina pectoris in the Framingham study. Prognosis and survival. Meijboom WB, Van Mieghem CA, van Pelt N, et al. Comprehensive assessment of coronary artery stenoses: computed tomography coronary angiography versus conventional coronary angiography and correlation with fractional flow reserve in patients with stable angina. Bamberg F, Truong QA, Blankstein R, et al. Usefulness of age and gender in the early triage of patients with acute chest pain having cardiac computed tomographic angiography. Alternative therapy for medically refractory angina: enhanced external counterpulsation and transmyocardial laser revascularization. Arora RR, Chou TM, Jain D, et al. The multicenter study of enhanced external counterpulsation (MUST- EECP): effect of EECP on exercise- induced myocardial ischemia and anginal episodes. Kumar A, Aronow WS, Vadnerkar A, et al. Effect of enhanced external counterpulsation on clinical symptoms, quality of life, 6- minute walking distance, and echocardiographic measurements of left ventricular systolic and diastolic function after 3. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4. Scandinavian Simvastatin Survival Study (4. S). Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower- than- average cholesterol concentrations, in the Anglo- Scandinavian Cardiac Outcomes Trial- -Lipid Lowering Arm (ASCOT- LLA): a multicentre randomi. Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. La. Rosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. Nissen SE, Tardif JC, Nicholls SJ, et al. Effect of torcetrapib on the progression of coronary atherosclerosis. Bots ML, Visseren FL, Evans GW, et al. Torcetrapib and carotid intima- media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double- blind trial. Ridker PM, Manson JE, Gaziano JM, et al. Low- dose aspirin therapy for chronic stable angina. A randomized, placebo- controlled clinical trial. Juul- Moller S, Edvardsson N, Jahnmatz B, et al. Double- blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST- segment elevation. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. Lacoste LL, Theroux P, Lidon RM, et al. Antithrombotic properties of transdermal nitroglycerin in stable angina pectoris. Norwegian Multicenter Study Group. Timolol- induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. Werdan K, Ebelt H, Nuding S, et al, for the ADDITIONS Study Investigators. Ivabradine in combination with metoprolol improves symptoms and quality of life in patients with stable angina pectoris: a post hoc analysis from the ADDITIONS trial. Miwa K, Miyagi Y, Igawa A, et al. Vitamin E deficiency in variant angina. Kaski JC, Rosano G, Gavrielides S, Chen L. Effects of angiotensin- converting enzyme inhibition on exercise- induced angina and ST segment depression in patients with microvascular angina. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus- eluting stent with a standard stent for coronary revascularization. Kastrati A, Mehilli J, Pache J, et al. Analysis of 1. 4 trials comparing sirolimus- eluting stents with bare- metal stents. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. COURAGE Trial Research Group. De Bruyne B, Pijls NH, Kalesan B, et al. Fractional flow reserve- guided PCI versus medical therapy in stable coronary disease. Allen KB, Dowling RD, Fudge TL, et al. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. Losordo DW, Schatz RA, White CJ, et al. Intramyocardial transplantation of autologous CD3. I/IIa double- blind, randomized controlled trial. Banai S, Ben Muvhar S, Parikh KH, et al. Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris: a prospective, open- label, multicenter, safety feasibility first- in- man study. ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Suppl 2): S1- 4. 5. American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis. National Lipid Association recommendations for patient- centered management of dyslipidemia: part 1 - executive summary. ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Developed with the special contribution of the Europ. ESC/EACTS guidelines on myocardial revascularization. ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: an update of the 2.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
November 2017
Categories |